Clinical characteristics of Japanese patients with moderate to severe COVID-19

INTRODUCTION: Although several reports on the risk factors for severe disease of COVID-19 already exist, reports on effective early indicators are still limited, especially from Japan. This study was conducted to clarify the patient’s characteristics whose disease progressed to severe status. METHOD...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Infect Chemother
Main Authors: Otoshi, Ryota, Hagiwara, Eri, Kitayama, Takaaki, Yamaya, Takafumi, Higa, Katsuyuki, Murohashi, Kota, Sato, Yozo, Tabata, Erina, Shintani, Ryota, Okabayashi, Hiroko, Ikeda, Satoshi, Niwa, Takashi, Nakazawa, Atsuhito, Oda, Tsuneyuki, Okuda, Ryo, Sekine, Akiamasa, Kitamura, Hideya, Baba, Tomohisa, Komatsu, Shigeru, Ogura, Takashi
Format: Artigo
Jezik:Inglês
Izdano: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931728/
https://ncbi.nlm.nih.gov/pubmed/33727024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2021.02.028
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki